PGNY Stock: Price, Earnings History and SEC Filings
Progyny, Inc. (PGNY) last traded at $29.19, up 2.78% on the latest session and up 15.9% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.34 against an analyst estimate of $0.28, a beat of 21.4%.
$29.19 +2.78%
1 month+15.88%
52-week high$33.07
52-week low$16.10
Volume807,727
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PGNY earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $0.34 | $0.28 | +21.43% |
| Mar 2026 | May 7, 2026 | $0.29 | $0.24 | +20.83% |
| Dec 2025 | Feb 26, 2026 | $0.14 | $0.13 | +7.69% |
| Sep 2025 | Nov 6, 2025 | $0.15 | $0.13 | +15.38% |
PGNY beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for PGNY
SEC filing data is not available right now. You can search for PGNY on SEC EDGAR.
PGNY news
- Progyny (PGNY) Cuts Guidance And Puts Its Valuation Back In FocusNov 1, 2026 · finance.yahoo.com
- Progyny (PGNY) Stock Looks About Right On Its 56% RunNov 1, 2026 · finance.yahoo.com
- Is Lower Revenue Guidance Altering The Investment Case For Progyny Stock (PGNY)?Nov 1, 2026 · finance.yahoo.com
- Progyny’s (PGNY) Full-Year Guidance Lowered on Utilization HeadwindsOct 30, 2026 · finance.yahoo.com
- Progyny stock study finds treatment gaps persist despite benefitsOct 29, 2026 · ad-hoc-news.de
- 1 cash-producing stock for long-term investors and 2 we find riskyOct 29, 2026 · finance.yahoo.com
- 3 Reasons to sell PGNY and 1 stock to buy insteadOct 28, 2026 · finance.yahoo.com
- New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to BenefitsOct 28, 2026 · finance.yahoo.com
About Progyny, Inc.
Progyny, Inc. (PGNY) is a US-listed public company on Nasdaq.